SYNTHOMYCIN
UkraineThe drug is used for the local treatment of purulent skin lesions (e.g., boils or carbuncles), purulent wounds, non-healing ulcers, second- and third-degree burns, as well as nipple cracks in breastfeeding women.
Frequently asked questions
How should Synthomycin be used correctly?
Apply the liniment in a thin layer to the affected area or soak gauze tampons with it, then apply a dressing. Dressings are changed once every 1–5 days, depending on the doctor's instructions. When treating nipple cracks, the nipple should be washed with a solution of ammonia spirit after breastfeeding, and then a sterile wipe with liniment should be applied.
Can the drug be used in children?
The drug is not prescribed to children during the first 4 weeks of life. In pediatric practice, treatment must be conducted only under medical supervision.
Who should not use this drug?
Contraindications include individual hypersensitivity to the components of the product, as well as psoriasis, eczema, and fungal skin diseases.
What are the possible side effects of Synthomycin?
Allergic reactions may occur, such as skin rash, itching, burning, redness (hyperemia), or swelling.
Can the drug be taken with other medicines?
Some drugs (e.g., erythromycin or nystatin) may enhance the effect of the liniment, while benzylpenicillin salts may reduce it. Synthomycin is incompatible with sulfanilamides, cytostatics, ethanol, barbiturates, and other specific substances.
Can the product be used during pregnancy or breastfeeding?
During pregnancy, it should be used with caution upon medical advice. When treating nipple cracks in postpartum women, breastfeeding does not need to be discontinued, but before feeding the child, any residue of the drug must be thoroughly removed from the skin and nipple.
Instructions for use
INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT SYNTOMICIN
Composition:
Active substance: 1 g of liniment contains chloramphenicol (syntomycin) – 50 mg;
Excipients: castor oil, emulsifier No. 1, sorbic acid, sodium carboxymethylcellulose, purified water;
Excipients included in emulsifier No. 1: cetyl alcohol, stearyl alcohol.
Pharmaceutical form. Liniment.
Main physico-chemical properties: liniment of white or white with a slightly yellowish tint, with a weak specific odor.
Pharmacotherapeutic group.
Antibiotics for topical use. Chloramphenicol. ATC code D06AX02.
Pharmacological properties.
The drug is active against strains of bacteria resistant to penicillin, streptomycin, and sulfonamides; against gram-positive (Staphylococcus spp., Streptococcus spp.) and gram-negative (Neisseria gonorrhoeae, Neisseria meningitidis) cocci, many bacteria (Escherichia coli, Haemophilus influenzae, Salmonella spp., Shigella spp., Klebsiella spp., Serratia spp., Proteus stuartii, Yersinia), rickettsiae, spirochetes, and causative agents of trachoma, psittacosis, and lymphogranuloma venereum. It exerts antimicrobial and antibacterial (bacteriostatic) action. The mechanism of action is associated with inhibition of microbial protein synthesis. Microbial resistance to chloramphenicol develops relatively slowly.
Clinical characteristics.
Indications.
Local treatment of purulent-inflammatory skin lesions (carbuncles, furuncles), purulent wounds, slowly healing trophic ulcers, II-III degree burns, and nipple fissures in lactating women.
Contraindications.
Individual hypersensitivity to any component of the drug.
Psoriasis, eczema, fungal skin diseases.
Interaction with other medicinal products and other forms of interactions.
Simultaneous use of the drug with erythromycin, oleandomycin, nystatin, and levorin enhances the antibacterial activity of the liniment, whereas concomitant use with benzylpenicillin salts reduces it. The drug is incompatible with sulfonamides.
The drug is incompatible with cytostatics, diphenyl, barbiturates and pyrazolone derivatives, and ethanol.
Special precautions for use.
It is not allowed for the liniment to get into the eyes. Unsupervised use of the drug in pediatric practice is prohibited; it should be used only as prescribed by a physician.
Topical antibacterial agents may lead to skin sensitization, resulting in the development of hypersensitivity reactions in the future (when these drugs are administered topically or in dosage forms intended for systemic action).
Use during pregnancy or breastfeeding.
Since the pharmacokinetics of Chloramphenicol has not been studied, the drug should be used with caution during pregnancy and only when, in the opinion of the physician, the expected benefit to the mother outweighs the potential risk to the fetus.
During treatment of nipple fissures in nursing mothers, breastfeeding need not be discontinued.
Before breastfeeding, any residual medication on the nipple and surrounding skin should be wiped off with a clean cloth, and the breast should be thoroughly and carefully washed.
Ability to influence reaction rate while driving or operating machinery.
Does not affect.
Administration and dosage.
Gauze swabs are soaked with the preparation or the preparation is applied directly in a thin layer to the affected area. A regular dressing is then applied, optionally with parchment or compress paper. Dressings are changed depending on indications every 1–3 days, sometimes every 4–5 days. The duration of treatment is determined individually by a physician.
For nipple fissures in postpartum women, after each feeding, nipples are washed with a 0.25% ammonia solution, then a sterile gauze pad coated with a layer of liniment is applied to the fissure. This rapidly relieves sharp pain, and fissures heal within 2–5 days after starting treatment.
Children.
Not prescribed for children during the first 4 weeks of life.
Overdose.
Symptoms: possible intensification of the drug's adverse effects.
Treatment: symptomatic.
Side effects.
Allergic reactions are possible (including skin rash, itching, burning sensation, hyperemia, swelling).
Shelf life. 2 years.
Storage conditions.
Store in the original packaging at a temperature not exceeding 25 °C. Do not freeze.
Keep out of reach of children.
After opening the tube, the preparation can be stored throughout the course of treatment.
Packaging.
25 g in tubes № 1.
Availability category. Over-the-counter.
Manufacturer.
JSC «Lubnipharm».
Manufacturer's address and location of its business activity.
16, Barvinkova St., Lubny, Poltava region, 37500, Ukraine
Similar drugs
| Brand name | Dosage form | Active substance / Dosage | Manufacturer |
|---|---|---|---|
| SYNTHOMYCIN | liniment |
|
JSC "Lubnipharm" |
The original data is available in the language of the country of manufacture.
Data source: State Register of Medicinal Products of Ukraine
Data last verified: August 13, 2026